FDA Registration for Baby Skincare Products
Which baby products are cosmetics and which are drugs, the diaper-cream and talc specifics, and how to register on each path.
Key Takeaways
- Baby lotion, oil, wash, shampoo = cosmetic — MoCRA registration + listing.
- Diaper rash cream = drug — skin protectant monograph (21 CFR Part 347).
- Baby sunscreen = drug — sunscreen is a drug at any age.
- Teething gels = drug — FDA warns against benzocaine for infant teething.
- Baby powder = talc/asbestos issue — FDA/MoCRA talc-asbestos testing; many use cornstarch.
- Infant products need a stronger safety file — and registration ≠ approval.
Which Baby Products Are Cosmetics vs Drugs
| Product | Category | Basis |
|---|---|---|
| Baby lotion, oil, moisturizing cream | Cosmetic | MoCRA |
| Baby wash / bath, baby shampoo, wipes | Cosmetic | MoCRA |
| Diaper rash cream / ointment | OTC drug | Skin protectant monograph (21 CFR 347) |
| Baby sunscreen | OTC drug | Sunscreen monograph |
| Teething gel | OTC drug | Drug (benzocaine FDA-warned for infants) |
| Eczema / antifungal / medicated baby products | OTC drug | Applicable drug monograph |
| Talc-based baby powder | Cosmetic (with a talc-safety issue) | MoCRA + asbestos testing |
Diaper Rash Cream Is a Skin Protectant Drug
The product parents reach for most — diaper rash cream — is not a cosmetic. A cream or ointment that protects against or treats diaper rash is an OTC drug under FDA's skin protectant monograph (21 CFR Part 347):
- Skin protectant actives — zinc oxide (1–25%), petrolatum (30–100%), dimethicone (1–30%), and others in the monograph
- Drug pathway — drug establishment registration, NDC listing, a Drug Facts label, monograph-compliant claims, cGMP, OMUFA, and a U.S. Agent if foreign
- Not cosmetic registration — a diaper rash product doesn't go through MoCRA
Baby Powder & the Talc Issue
Talc-based baby powder carries a specific, well-known concern: talc can be contaminated with asbestos, a known carcinogen. It's one of the most scrutinized areas in baby care.
- FDA tests cosmetic talc for asbestos, and contamination has driven recalls and litigation
- Many manufacturers switched to cornstarch-based powders
- MoCRA directed FDA to set standardized talc-asbestos testing methods for talc-containing cosmetics (FDA issued a proposed rule in late 2024)
- If you make a talc-containing baby powder, asbestos testing and documentation are essential parts of your safety substantiation
The Cosmetic (MoCRA) Path & Infant Safety
- Facility registration + product listing + Responsible Person — via Cosmetics Direct; biennial renewal; U.S. Agent if foreign
- Safety substantiation — held to a higher bar in practice — infant skin is more sensitive and permeable, so careful ingredient selection, irritation/dermatological data, and preservative-efficacy/microbial testing matter
- Adverse-event reporting — serious events within 15 business days; records kept
- Compliant labeling — INCI, net quantity, adverse-event contact; truthful claims (there's no FDA definition for "hypoallergenic" or "tear-free," so support them and don't mislead)
Common Baby Skincare Mistakes
- Treating a diaper rash cream as a cosmetic — it's a skin protectant drug
- Treating baby sunscreen as a cosmetic — sunscreen is a drug
- A treatment claim (diaper rash, eczema) on a cosmetic lotion — makes it a drug
- Ignoring the talc/asbestos issue for a talc baby powder
- Thin safety substantiation for an infant product
- Missing the U.S. Agent (foreign); "FDA approved" claims
Get Your Baby Skincare Line Compliant
FDA Registration Assistance classifies each product first — cosmetic (lotion, oil, wash, shampoo) or drug (diaper rash cream, sunscreen, teething, medicated) — then handles the right registration: MoCRA facility registration and product listing for baby cosmetics, or drug establishment registration, NDC listing, Drug Facts, and monograph compliance for baby drugs — plus the heightened safety substantiation and talc considerations infant products call for, and a U.S. Agent if you're foreign.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Frequently Asked Questions — Baby Skincare
1. Do baby skincare products require FDA registration?
Most do, but which registration depends on the product. Baby lotions, oils, washes, shampoos, and plain moisturizing creams are cosmetics and register under MoCRA: facility registration, product listing, a Responsible Person, safety substantiation, adverse-event reporting, and labeling (with a U.S. Agent if foreign). But several common baby products are OTC drugs - diaper rash creams, baby sunscreen, teething gels, and medicated (eczema/antifungal) products - and register on the drug pathway. Classification comes first.
2. Is diaper rash cream a cosmetic or a drug?
A drug. A diaper rash cream or ointment that protects against or treats diaper rash is an OTC drug under FDA's skin protectant monograph (21 CFR Part 347). Its actives are skin protectants like zinc oxide (1–25%), petrolatum (30–100%), and dimethicone (1–30%). So a diaper rash product needs the drug pathway - drug establishment registration, NDC listing, a Drug Facts label, monograph-compliant actives and claims, and cGMP - not cosmetic registration.
3. Which baby products are cosmetics and which are drugs?
Cosmetics (MoCRA): baby lotion, baby oil, baby wash/bath, baby shampoo, and plain moisturizing creams and wipes marketed to cleanse or moisturize. Drugs (drug pathway): diaper rash cream/ointment (skin protectant), baby sunscreen (sunscreen monograph), teething gels, and eczema or antifungal "treatment" products. A product's claims and actives decide the bucket - "moisturizes baby's skin" is cosmetic; "treats diaper rash" or "SPF 30" is a drug.
4. Is baby sunscreen a drug?
Yes. Sunscreen is an OTC drug in the U.S. regardless of the target age, because sun protection is a drug claim - so baby sunscreen follows the drug pathway (establishment registration, NDC listing, Drug Facts, the sunscreen monograph). FDA also generally advises keeping infants under 6 months out of direct sun rather than relying on sunscreen, which is worth reflecting in marketing. Either way, a baby sunscreen is regulated as a drug, not a cosmetic.
5. What about baby powder and talc?
Talc-based baby powder carries a specific safety concern: talc can be contaminated with asbestos, a known carcinogen. FDA tests cosmetic talc products, and many manufacturers have switched from talc to cornstarch. MoCRA also directed FDA to establish standardized methods for detecting and identifying asbestos in talc-containing cosmetics (FDA issued a proposed rule in late 2024). If you make a talc-containing baby powder, asbestos testing and documentation are essential parts of your safety substantiation.
6. Are teething gels regulated as drugs?
Yes - a teething product that numbs or treats is a drug, not a cosmetic. And there's a specific safety caution: FDA has warned that benzocaine oral products (including teething gels) should not be used for teething in infants and children under 2, due to the risk of methemoglobinemia, and asked companies to stop marketing OTC benzocaine teething products. So a teething product is a drug, and benzocaine for infant teething is off the table.
7. Is safety substantiation different for baby products?
MoCRA's requirement is the same - adequate safety substantiation with records kept - but for products used on infants, the expectation in practice is higher, because infant skin is more sensitive and permeable. That typically means careful ingredient selection, dermatological/irritation and patch data, preservative-efficacy and microbial testing for water-based products, and toxicological review appropriate to infant use. There isn't a separate FDA "infant" standard, but the safety file should reflect the vulnerable population.
8. What is the cosmetic (MoCRA) path for baby skincare?
For baby cosmetics (lotion, oil, wash, shampoo, plain cream): register the manufacturing facility with FDA (via Cosmetics Direct, with an FEI, and a U.S. Agent if foreign), list each product, designate a Responsible Person, maintain safety substantiation, set up adverse-event reporting, and use compliant labeling. Facility registration renews every two years and listings update at least annually.
9. What is the drug path for baby products?
For baby drugs (diaper rash cream, sunscreen, teething, medicated): drug establishment registration (21 CFR Part 207), an NDC listing for each product, a Drug Facts label, monograph-compliant actives and claims (for example the skin protectant monograph, 21 CFR Part 347, for diaper rash), cGMP, OMUFA fees, and a U.S. Agent if foreign. Drug establishment registration renews annually. It's the same framework as other OTC monograph drugs.
10. Does "hypoallergenic" or "tear-free" need proof?
There's no FDA standard or definition for "hypoallergenic," so the claim doesn't have a fixed testing requirement - but it must not be misleading, and you should be able to support it. "Tear-free" is similarly a marketing claim that needs to be truthful and substantiated. Neither term changes the product's classification: a "tear-free hypoallergenic" baby wash is still a cosmetic that must comply with MoCRA, and the claims still have to be backed up.
11. Do foreign baby skincare brands need to register?
Yes. Any baby product marketed in the U.S. must comply regardless of where it's made, and foreign facilities need a U.S. Agent on either pathway. A foreign baby cosmetic registers under MoCRA with a U.S. Agent; a foreign diaper rash cream or baby sunscreen registers as a drug establishment with a U.S. Agent. Home-country classification doesn't transfer - some baby products treated as cosmetics abroad are drugs here.
12. Does "natural" or "organic" baby skincare still need to comply?
Yes. "Natural," "clean," and "organic" are marketing terms that don't change regulatory status. A natural baby lotion is still a cosmetic under MoCRA and needs the same registration, listing, safety substantiation, and labeling - and if a "natural" product makes a diaper rash or other treatment claim, it's still a drug. Parents' preference for natural products makes safety substantiation and honest labeling especially important.
13. What labeling do baby skincare products need?
A baby cosmetic needs cosmetic labeling: a Principal Display Panel (statement of identity, net quantity) and an information panel (INCI ingredient declaration, responsible-party name/address, any required warnings, and the MoCRA adverse-event contact), with no drug claims or "FDA Approved." A baby drug (diaper cream, sunscreen) needs a Drug Facts panel. The label must match the classification, and claims aimed at parents must be truthful and non-misleading.
14. Does registering my baby skincare mean it's FDA-approved?
No. FDA doesn't approve cosmetics, and OTC monograph drugs (like a compliant diaper rash cream) are "compliance, not approval." So neither a baby cosmetic nor a monograph baby drug is "FDA-approved." Calling a baby product "FDA-approved" because it's registered is misleading - which matters even more for products marketed to parents. Describe it accurately: a registered/listed cosmetic, or a monograph-compliant OTC drug.
15. What are common baby skincare mistakes?
Treating a diaper rash cream (a skin protectant drug) as a cosmetic; treating baby sunscreen as a cosmetic; putting a treatment claim (diaper rash, eczema) on a cosmetic baby lotion; ignoring the talc/asbestos issue for baby powder; thin safety substantiation for an infant product; missing the U.S. Agent (foreign); and "FDA approved" claims. Most trace back to not classifying each product - cosmetic vs drug - first.
16. How does FDA Registration Assistance help baby skincare brands?
We classify each product first - cosmetic (lotion, oil, wash, shampoo) or drug (diaper rash cream, sunscreen, teething, medicated) - then handle the right registration: MoCRA facility registration and product listing (with Responsible Person, U.S. Agent, safety, and labeling) for baby cosmetics, or drug establishment registration, NDC listing, Drug Facts, and monograph compliance for baby drugs - and we help with the heightened safety substantiation and talc considerations that infant products call for. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.
